SOLVAR LIMITED (SVR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SVR

SVR - SOLVAR LIMITED

FNArena Sector : Business & Consumer Credit
Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: 5.99
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.58

13 Apr
2026

-0.045

OPEN

$1.62

-2.77%

HIGH

$1.64

126,775

LOW

$1.58

TARGET
$2.00 26.6% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
BTN . CCP . CGR . COG . EML . EPY . FND . FSA . HUM . JDO . LFS . MME . PLT . PNC . PPM . QAL . SIV . TYR . WZR . XYZ . ZIP .
FNARENA'S MARKET CONSENSUS FORECASTS
SVR: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx 15.5 18.0 xxx
DPS (cps) xxx 14.0 13.0 xxx
EPS Growth xxx 90.4% 16.3% xxx
DPS Growth xxx N/A - 7.1% xxx
PE Ratio xxx N/A 8.9 xxx
Dividend Yield xxx N/A 8.1% xxx
Div Pay Ratio(%) xxx 90.4% 72.2% xxx

Dividend yield today if purchased 3 years ago: 8.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

8.75

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 11/12 - ex-div 2.5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx15.5
DPS All xxxxxxxxxxxxxxx14.0
Sales/Revenue xxxxxxxxxxxxxxx207.4 M
Book Value Per Share xxxxxxxxxxxxxxx179.5
Net Operating Cash Flow xxxxxxxxxxxxxxx49.5 M
Net Profit Margin xxxxxxxxxxxxxxx15.15 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx8.73 %
Return on Invested Capital xxxxxxxxxxxxxxx4.80 %
Return on Assets xxxxxxxxxxxxxxx3.17 %
Return on Equity xxxxxxxxxxxxxxx8.73 %
Return on Total Capital xxxxxxxxxxxxxxx9.97 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx26.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx379 M
Long Term Debt xxxxxxxxxxxxxxx209 M
Total Debt xxxxxxxxxxxxxxx589 M
Goodwill - Gross xxxxxxxxxxxxxxx19 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx99 M
Price To Book Value xxxxxxxxxxxxxxx0.93

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx0.3 M
Capex % of Sales xxxxxxxxxxxxxxx0.15 %
Cost of Goods Sold xxxxxxxxxxxxxxx19 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx92 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx12 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

19/02/2026

2

Downgrade to Accumulate from Buy

$2.00

26.58%

Morgans downgrades Solvar to Accumulate from Buy with a higher target of $2 from $1.85 post interim results.

The results came in above the broker's expectations with normalised net proft after growth of $20m.  Net interest income of $74.3m missed, and net interest margin contracted to 16.4%, reflecting mix changes and NZ roll-off, while bad debts improved to 2.9%.

The Australian loan book grew, supported by a record half from AFS and continued traction from Bennji, while NZ receivables reduced to around $50m.

Management reiterated FY26 net profit after guidance of around $36m implying a 2H skew and improving book growth momentum into 2H26.

Morgans lifts net profit forecats for FY26-FY28 by 5%/1%1%, respectively.

FORECAST
Morgans forecasts a full year FY26 dividend of 13.00 cents and EPS of 18.00 cents.
Morgans forecasts a full year FY27 dividend of 13.00 cents and EPS of 20.00 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

23/02/2026

1

Buy

$2.00

26.58%

Canaccord Genuity highlights Solvar continues to focus on capital management with1H26 closing gross loan book of $897m down -4% y/y, net interest income of $74.3m, down -9% y/y, and normalised NPAT of $20.0m, up 6% y/y.

Profitability benefited from an NZ$8m sale of the written-off loan book. An interim dividend of 6cps and a 2.5cps special dividend were declared, taking the last 12-month dividends to 19cps, and the buyback saw 11.5% of shares repurchased in recent years.

Management reiterated FY26 guidance for normalised NPAT of $36m, and the broker makes minor forecast revisions to reflect a lower closing book and higher employee costs, positioning for measured earnings growth into FY27.

Canaccord Genuity retains a Buy rating and $2.00 target price.

FORECAST
Canaccord Genuity forecasts a full year FY26 dividend of 19.00 cents and EPS of 19.00 cents.
Canaccord Genuity forecasts a full year FY27 dividend of 14.00 cents and EPS of 19.00 cents.

SVR STOCK CHART